<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01962116</url>
  </required_header>
  <id_info>
    <org_study_id>QUENOT DB 2012</org_study_id>
    <nct_id>NCT01962116</nct_id>
  </id_info>
  <brief_title>Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU</brief_title>
  <acronym>VERROU-REA</acronym>
  <official_title>Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU = Multicentre, Controlled, Randomised Superiority Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      After obtaining written informed consent and inclusion, patients will be randomised into 2&#xD;
      groups for the type of dialysis catheter lock:&#xD;
&#xD;
        -  The first group will have a citrate lock&#xD;
&#xD;
        -  The second group will have a heparin lock Patients will be stratified according to the&#xD;
           centre and type of Renal Replacement Therapy (RRT) continuous or intermittent.&#xD;
&#xD;
      The daily surveillance of patients will not be different from the usual surveillance of&#xD;
      patients on Renal Replacement Therapy.&#xD;
&#xD;
      The hemodialysis catheters used will be specific Renal Replacement Therapy catheters.&#xD;
&#xD;
      The decision to withdraw the catheter will be made by the investigator and based on clinical&#xD;
      criteria (complications related to the catheter, termination of Renal Replacement Therapyâ€¦)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 14, 2013</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">April 1, 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of event-free survival of the first non-tunneled hemodialysis catheter (defined at the time in days from catheter insertion to withdrawal whatever the reason)</measure>
    <time_frame>up to 28 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">405</enrollment>
  <condition>Patients With Acute Renal Insufficiency</condition>
  <arm_group>
    <arm_group_label>Heparin lock</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Citrate lock</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Citrate 4%</intervention_name>
    <arm_group_label>Citrate lock</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>unfractionated heparin</intervention_name>
    <arm_group_label>Heparin lock</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged &gt; 18 years&#xD;
&#xD;
          -  Requiring RRT for acute renal insufficiency&#xD;
&#xD;
          -  For which a 1st non-tunneled catheter is placed&#xD;
&#xD;
          -  In the jugular or femoral position&#xD;
&#xD;
          -  After written informed consent has been obtained from the patient, a member of the&#xD;
             family or a person of trust&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient presenting active poorly controlled bleeding&#xD;
&#xD;
          -  Known allergy to citrate&#xD;
&#xD;
          -  Acute liver failure (Prothrombin level &lt;30%)&#xD;
&#xD;
          -  Thrombopenia &lt; 30 000/mm3&#xD;
&#xD;
          -  Known or suspected heparin-induced thrombopenia&#xD;
&#xD;
          -  Known systemic bacterial infection at the time the catheter is placed&#xD;
&#xD;
          -  catheter in the subclavicular position&#xD;
&#xD;
          -  Persons not affiliated to a national health insurance scheme&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Adults under guardianship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 27, 2013</study_first_submitted>
  <study_first_submitted_qc>October 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2013</study_first_posted>
  <last_update_submitted>August 14, 2018</last_update_submitted>
  <last_update_submitted_qc>August 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Calcium heparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

